Skip to main content
. 2014 Oct 15;4(1):112–124. doi: 10.1002/cam4.351

Figure 2.

Figure 2

Poor prognosis of patients with 9p24.1-p13.3 loss in primary ccRCCs. (A) Recurrence-free survival rates (shown by Kaplan–Meier curve) for six patients with 9p24.1-p13.3 loss in primary ccRCCs, excluding four patients with stage IV disease, were lower than those for 10 patients without 9p24.1-p13.3 loss (P = 0.0089 determined by log-rank test). (B) Cancer-specific survival rates (shown by Kaplan–Meier curve) for 10 patients with 9p24.1-p13.3 loss in primary ccRCCs were lower than those for 10 patients without 9p24.1-p13.3 loss (P = 0.0006 determined by log-rank test).